Leinco Technologies

Mouse IgG2a Isotype Control - Purified in vivo PLATINUM™ Functional Grade

Product Code:
 
LEI-P381
Product Group:
 
Isotype Controls
Host Type:
 
Mouse
Antibody Isotype:
 
IgG2a κ
Antibody Clonality:
 
Isotype Control
Antibody Clone:
 
C1.18.4
Regulatory Status:
 
RUO
Application:
 
In Vivo Assay
Shipping:
 
2-8°C
Storage:
 
Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.
 

No additional charges, what you see is what you pay! *

CodeSizePrice
LEI-P381-1.0mg1.0 mg£283.00
Quantity:
LEI-P381-5.0mg5.0 mg£456.00
Quantity:
LEI-P381-25mg25 mg£1,335.00
Quantity:
LEI-P381-50mg50 mg£1,938.00
Quantity:
LEI-P381-100mg100 mg£2,741.00
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: US.
Typical lead time: 14-21 working days.
Contact us for more accurate information.
  • Further Information
  • References
  • Show All

Further Information

Concentration:
? 5.0 mg/ml
Conjugate/Tag/Label:
Purified in vivo Functional Grade, in vivo PLATINUM™
Format:
This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added.
Formulation:
This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added.
Purity:
?98% monomer by analytical SEC, >95% by SDS Page

References

1. Ikeda Y. et al. (2003) Blood.101(2):621-3. Article Link 2. Wright, TM et al. (2000) J Immunol.164(12):6138-46.PubMed 3. Wright, TM et al. (2001) Arthritis Rheum. 44(7):1654-9. PubMed 4. Nishikawa, Takeji et al. (2000) Journal of Investigative Dermatology 114(1): 88-94. PubMed